NEK1’s potential role in phosphorylating this site may serve to stabilize cyclin F, enhancing VCP ATPase activity and promoting subsequent TDP-43 aggregation, which is a central pathological feature in ALS. Here, VCP is linked to amyotrophic lateral sclerosis.